Protein Misfolding and Aggregation: From Molecular Mechanisms to Human Diseases

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Biophysics".

Deadline for manuscript submissions: 20 July 2025 | Viewed by 516

Special Issue Editors


E-Mail Website
Guest Editor
St. Jude Children's Research Hospital, Memphis, TN, USA
Interests: biomolecular condensates; amyloid fibrils; neurodegenerative diseases; intrinsically disordered proteins

E-Mail Website
Co-Guest Editor
St. Jude Children's Research Hospital, Memphis, TN, USA
Interests: neurodegenerative diseases; protein

Special Issue Information

Dear Colleagues,

Most proteins in the cell need to fold into defined three-dimensional structures to accomplish their evolutionarily derived functions. Protein folding is a nuanced process encoded by, and dependent on, the intrinsic properties of the primary amino acid sequence as well as cellular protein quality control machinery such as chaperons and protein degradation systems. Misfolded proteins can aggregate into toxic oligomers, or amyloid fibrils, and are associated with diseases including Alzheimer’s and Parkinson’s diseases as well as type II diabetes. These amyloid deposits share a common cross-β structure regardless of their primary amino acid sequences. Recent studies have demonstrated biomolecular condensate formation as an additional commonality inherent to some amyloid-forming proteins. The emergent biophysical properties of condensates can modulate protein aggregation; thus, an understanding of the structural and kinetic basis of amyloid formation as well as the protein quality control machinery is important for understanding protein misfolding diseases and the downstream development of therapeutics. This Special Issue calls for diverse and comprehensive overviews that illustrate protein misfolding and neurodegenerative diseases from biophysical, biochemical, or cellular biological perspectives.

Dr. Xinrui Gui
Dr. Jinjun Wu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • protein aggregation
  • amyloid fibrils
  • protein quality control
  • neurodegenerative diseases

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

20 pages, 2698 KiB  
Article
NMR Metabolomic Profiling of Differentiated SH-SY5Y Neuronal Cells: Amyloid-β Toxicity and Protective Effects of Galantamine and Lycorine
by Arian Kola, Filippo Costanti, Jordan Kahfi, Abdul-Hamid Emwas, Mariusz Jaremko and Daniela Valensin
Cells 2025, 14(7), 525; https://doi.org/10.3390/cells14070525 - 1 Apr 2025
Viewed by 360
Abstract
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by metabolic dysregulation, oxidative stress, amyloid-β (Aβ) aggregation, metal dyshomeostasis, and mitochondrial dysfunction. Current treatments provide only symptomatic relief, highlighting the need for novel therapeutic strategies. This study investigates the metabolic effects of the [...] Read more.
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by metabolic dysregulation, oxidative stress, amyloid-β (Aβ) aggregation, metal dyshomeostasis, and mitochondrial dysfunction. Current treatments provide only symptomatic relief, highlighting the need for novel therapeutic strategies. This study investigates the metabolic effects of the alkaloids galantamine (GAL) and lycorine (LYC) in differentiated SH-SY5Y neuroblastoma cells, an established in vitro model for AD, which acquire a neuronal phenotype upon differentiation. Using untargeted and targeted NMR-based metabolomics combined with multivariate statistical analysis, we analyzed extracellular metabolic profiles under basal conditions and following Aβ42 exposure, both in the presence and absence of GAL and LYC. Our findings reveal distinct metabolic responses to Aβ toxicity, with significant alterations in pyruvate and glutamine metabolism. Both GAL and LYC contributed to the restoration of glutamine and lysine homeostasis, but LYC had a more pronounced effect, better sustaining cellular energy balance and mitochondrial function. Unlike LYC, GAL treatment was associated with pyruvate accumulation, highlighting a distinct metabolic response between the two compounds. These variations may reflect distinct mechanisms of action, potentially influencing their therapeutic roles in counteracting Aβ-induced toxicity. This study highlights the value of metabolic profiling for assessing neuroprotective agents and reinforces the potential of natural alkaloids in this context. Full article
Show Figures

Figure 1

Back to TopTop